Impax Laboratories Inc (NASDAQ:IPXL)

18.85
Delayed Data
As of Apr 26
 -0.40 / -2.08%
Today’s Change
12.80
Today|||52-Week Range
25.70
+13.21%
Year-to-Date
New Strong Sell Stocks for April 26th
Apr 26 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close19.25
Today’s open19.20
Day’s range18.70 - 19.30
Volume516,283
Average volume (3 months)942,179
Market cap$1.5B
Data as of 4:00pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)+1.51%
Earnings growth (this year)+68.48%
Earnings growth (next 5 years)+28.50%
Revenue growth (last year)-5.90%
P/E ratioNM
Price/Sales1.54
Price/Book7.87

Competitors

 Today’s
change
Today’s
% change
AKCAAkcea Therapeutics I...-1.16-4.32%
INVAInnoviva Inc-0.19-1.30%
FWPForward Pharma A/S+0.12+5.97%
PCRXPacira Pharmaceutica...-0.05-0.14%
Data as of 4:00pm ET, 04/26/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)$0.19
Annual revenue (last year)$775.8M
Annual profit (last year)-$469.3M
Net profit margin-60.49%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Paul M. Bisaro
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts